21:52 Beijing time on October 1st, 2021Teligent Inc New (TLGT.us)The stock changed, and the stock price quickly fell by 5.01%. As of press time, the stock was trading at US $0.379 per share, with a turnover of 968683 shares, a turnover rate of 1.04% and an amplitude of 4.44%.
Recent earnings data show that the stock achieved operating income of $10.43 million, net profit of-$12.87 million, earnings per share of-$0.14, gross profit of-$2.70 million and a price-earnings ratio of-0.05 times.
In terms of agency rating, there is currently no agency to make "buy, hold, sell" recommendations on the stock.
In the pharmaceutical industry in which Teligent Inc New shares are located, the overall decline was 0.68 per cent. Among its related stocksZomedica Corp、Clarus Therapeutics Hldgs Inc C/Wts 11 + 08 * 2026 (To Pur Com)、MerckThe increase is relatively large, Zomedica Corp,Sonoma Pharmaceuticals Inc、Denawi PharmaceuticalsRelatively active, with turnover rates of 3.20%, 2.25% and 1.58%, respectively. The related stocks with large amplitudes are Denawi Pharmaceuticals, Zomedica Corp,Shineco, Inc. co., Ltd.The amplitudes are 12.47%, 9.02% and 8.52%, respectively.
About Teligent Inc New: Teligent Inc is a professional generic drug company. Teligent develops, manufactures and markets (under its own trademark) local, injection, composite and ophthalmic pharmaceutical products in the United States and Canada. The product portfolio includes hospital-based sterile injections and topical medications (such as creams such as Synalar and Spectazole; lotions such as Kenalog; ointments such as Topicort and Kenalog; and topical drugs such as Pennsaid and Xylocaine). The company also serves the pharmaceutical, over-the-counter and cosmetics markets.
(the above content is completed by Money Call, a self-selected intelligent machine writer, and is only used as a reference for users to look at the market, not as a basis for transaction. )